Expand Document | Expand Chapter | Full TOC | Printable HTML version
Les comités pharmaceutiques et thérapeutiques - Guide pratique
(2004; 160 pages) [English] [Spanish] View the PDF document
Table of Contents
View the documentAbréviations
View the documentPréface
Open this folder and view contents1. Introduction
Open this folder and view contents2. Structure et organisation d'un comité pharmaceutique et thérapeutique
Open this folder and view contents3. Gestion du processus du formulaire
Open this folder and view contents4. Evaluation des nouveaux médicaments
Open this folder and view contents5. Assurer l'innocuité et la qualité des médicaments
Open this folder and view contents6. Outils pour l'étude de l'utilisation des médicaments
Open this folder and view contents7. Promotion de l'usage rationnel des médicaments
Open this folder and view contents8. Antimicrobiens et injections
Open this folder and view contents9. Pour démarrer
View the documentGlossaire1
View the documentBibliographie
View the documentPour en savoir plus
View the documentAdresses et sites Internet utiles
 

Pour en savoir plus

American Society of Health-System Pharmacists (1992) Guidelines on formulary system management. American Journal of Hospital Pharmacy 49: 648-652.

American Society of Health-System Pharmacists (1992) ASHP statement on the pharmacy and therapeutics committee. American Journal of Hospital Pharmacy 49: 2008-2009.

British Medical Association and Royal Pharmaceutical Society of Great Britain (publication permanente) British national formulary, mis à jour tous les 6 mois. BMJ Books, London.

Gehlbach, SH (1993) Interpreting the medical literature, 3rd edn. McGraw-Hill, New York,

Hogerzeil HV, Ross-Degnan R, Laing RO, et al. (1993) Field tests for rational drug use in twelve developing countries. Lancet 342: 1408-10.

Management Sciences for Health (1997) Managing drug supply, 2nd edn. Kumarian Press, West Hartford, CT. ISBN: 1-56549-047-9. Voir notamment chapitre 3, 'Economics for drug management'; chapitre 29 'Investigating drug use', chapitre 30, 'Drug and therapeutics information', chapitre 31 'Promoting rational prescribing'; chapitre 38, 'Hospital drug services'; chapitre 41, 'Analysing and controlling drug expenditures'; Partie III Section A, 'Selection'.

OMS (1989) Comment estimer les besoins en médicaments: manuel pratique. Organisation mondiale de la Santé, Genève. WHO/DAP/88.2.

OMS (1992) Injection practices research. Organisation mondiale de la Santé, Genève. WHO/DAP/92.9.

OMS (1994) Injection practices: a case study of Thailand. Organisation mondiale de la Santé, Genève. WHO/DAP/94.8.

OMS (1994) Critères éthiques applicables à la promotion des médicaments: rapport du Directeur Général. Organisation mondiale de la Santé, Genève.

OMS (1996) Injection practices in the developing world: a comparative review of field studies in Uganda and Indonesia. Organisation mondiale de la Santé, Genève. WHO/DAP/96.4.

OMS (1999) Principes opérationnels de bonnes pratiques pour les achats de produits pharmaceutiques. Organisation mondiale de la Santé, Genève. WHO/EDM/PAR/99.5.

OMS (2001) WHO global strategy for the containment of antimicrobial resistance. Département Maladies transmissibles: surveillance et action, Organisation mondiale de la Santé, Genève.

OMS (2001) Teachers guide to good prescribing. Organisation mondiale de la Santé, Genève. WHO/EDM/PAR/2001.2.

Prüss A, Giroult E, Rushbrook P (1999) Safe management of wastes from health care activities. Organisation mondiale de la Santé, Genève.

Sanchez LA (1999) Applied pharmacoeconomics: evaluation and use of pharmacoeconomic data from the literature. American Journal of Health System Pharmacy 56(16): 1630-1638.

South African medicines formulary (1998) 3rd edn. Medical Association of South Africa Publications, Cape Town.

 

to previous section to next section
 

Last updated: May 3, 2013